[Biopharmaceutical studies of drugs. III. Serum concentration level of o-ethoxybenzamide and N-(beta-hydroxybutyryl)-p-phenetidine after simultaneous administration to rabbit (author's transl)].
K Kigasawa et al.
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 101(6), 556-566 (1981-06-01)
Mechanism of metabolic activation of the analgetic bucetin to bacterial mutagens by hamster liver microsomes.
T Nohmi et al.
Chemical & pharmaceutical bulletin, 33(7), 2877-2885 (1985-07-01)
[Biopharmaceutical studies of drugs (6). Effect of 2-bromo-isovalerylurea on serum concentrations of O-ethoxybenzamide and N-(beta-hydroxybutyryl)-p-phenetidine in rabbits].
K Kigasawa et al.
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 103(5), 559-565 (1983-05-01)
[Biopharmaceutical studies of drugs (7). Inhibitory effect of urea derivatives on de-ethylation of O-ethoxybenzamide and N-(beta-hydroxybutyryl)-p-phenetidine].
K Kigasawa et al.
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 103(5), 566-572 (1983-05-01)
Journal of the National Cancer Institute, 79(5), 1151-1158 (1987-11-01)
The carcinogenicity of bucetin [(3-hydroxy-p-butyrophenetidide) CAS: 1083-57-4], an antipyretic analgesic drug, was examined in 300 (C57BL/6 X C3H)F1 mice. Groups of 50 mice of each sex were treated with 1.5 or 0.75% bucetin in their basal diet for 76 weeks
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.